Switch to:
More From Other Websites
Stock Market Video Analysis for Week Ending 2/27/15 Feb 28 2015
Final Glance: Biotechnology companies Feb 27 2015
Bellevue city manager: Keeping Expedia in Bellevue a 'top priority' Feb 27 2015
Expedia may move to Amgen's former Seattle campus Feb 27 2015
Midday Glance: Biotechnology companies Feb 27 2015
Early Glance: Biotechnology companies Feb 27 2015
The Zacks Analyst Blog Highlights: Pharmacyclics, Celgene, Amgen and Regeneron - Press Releases Feb 27 2015
Amgen Announces The European Medicines Agency Acceptance Of Kyprolis® (Carfilzomib) Marketing... Feb 27 2015
Amgen Receives Positive CHMP Opinion For Use Of Vectibix® (panitumumab) As First-Line Treatment In... Feb 27 2015
9:00 am Amgen announces that the CHMP of the EMA adopted a positive opinion to extend the marketing... Feb 27 2015
Amgen Receives Positive CHMP Opinion For Use Of Vectibix® (panitumumab) As First-Line Treatment In... Feb 27 2015
Amgen Announces Results from Phase 3 Clinical Study Comparing AMG 416/ONO-5163 with Cinacalcet... Feb 27 2015
Amgen Announces the European Medicines Agency Acceptance of Kyprolis® (carfilzomib) Marketing... Feb 26 2015
Amgen Announces The European Medicines Agency Acceptance Of Kyprolis® (Carfilzomib) Marketing... Feb 26 2015
Short Sellers Come Back To Biotech Stocks Feb 26 2015
AMGEN INC Financials Feb 26 2015
Amgen Reports Encouraging Late-Stage Data on AMG 416 - Analyst Blog Feb 26 2015
Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog Feb 26 2015
Short Sellers Increase Bets Against Biotech as Shares Continue to Rise Feb 26 2015
Amgen Drug Shows Positive Results in Late-Phase Study Feb 25 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK